All In MedTech

FDA Clearance Tracker · P990078-S005

HYPERION LTK SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 8, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 8, 2002

Approved

Time to decision

261 days

Received Aug 20, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P990078-S005
Device name
HYPERION LTK SYSTEM
Applicant location
Fremont, CA
Received
Aug 20, 2001
Decided
May 8, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P990078

Device type

Device class
Class II
Regulation
21 CFR 886.4390
Specialty
Ophthalmology

Every decision under product code HQF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT A-PLUS/C-MAC, FREMONT, CALIFORNIA.

Source documents

Other decisions for Sunrise Technologies, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.